1. miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer
   Boye Schnack Nielsen et al, 2014, Frontiers in Oncology CrossRef
2. Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets
   Cecilia Pop-Bica et al, 2017, International Journal of Molecular Sciences CrossRef
3. Non-coding RNA and autophagy: Finding novel ways to improve the diagnostic management of bladder cancer
   Ishaq Tantray et al, 2023, Frontiers in Genetics CrossRef
4. MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1
   Peng Li et al, 2017, Cellular Physiology and Biochemistry CrossRef
5. CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma
   Jiancheng Lv et al, 2021, Frontiers in Oncology CrossRef
6. Lab in a Tube: Sensitive Detection of MicroRNAs in Urine Samples from Bladder Cancer Patients Using a Single-Label DNA Probe with AIEgens
   Xuehong Min et al, 2015, ACS Applied Materials & Interfaces CrossRef
7. Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy
   Ruth L. Vinall et al, 2016, Genes & Cancer CrossRef
8. Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
   Mathijs P. Scholtes et al, 2021, Cancers CrossRef
9. MIMRDA: A Method Incorporating the miRNA and mRNA Expression Profiles for Predicting miRNA-Disease Associations to Identify Key miRNAs (microRNAs)
   Xianbin Li et al, 2022, Frontiers in Genetics CrossRef